Evidence map›Paper›PMID 33173537›Full record

ArticleFrontiers in genetics2020

Yujuan Gui, Mélanie H Thomas, Pierre Garcia, Mona Karout, Rashi Halder, Alessandro Michelucci, Heike Kollmus, Cuiqi Zhou, Shlomo Melmed, Klaus Schughart and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 3 countries.

Yujuan GuiDepartment of Life Sciences and Medicine, University of Luxembourg, Belvaux, Luxembourg.
Mélanie H ThomasLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.
Pierre GarciaLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.
Mona KaroutLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.
Rashi HalderLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.
Alessandro MichelucciLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.
Heike KollmusDepartment of Infection Genetics, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Cuiqi ZhouCedars Sinai Medical Centre, Los Angeles, CA, United States.
Shlomo MelmedCedars Sinai Medical Centre, Los Angeles, CA, United States.
Klaus SchughartDepartment of Infection Genetics, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Rudi BallingLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.
Michel MittelbronnLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.
Joseph H NadeauPacific Northwest Research Institute, Seattle, WA, United States.
Robert W WilliamsDepartment of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN, United States.
Thomas SauterDepartment of Life Sciences and Medicine, University of Luxembourg, Belvaux, Luxembourg.
Manuel ButtiniLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.
Lasse SinkkonenDepartment of Life Sciences and Medicine, University of Luxembourg, Belvaux, Luxembourg.
University of Luxembourg · LUCedars-Sinai Medical Center · USHelmholtz Centre for Infection Research · DECentre Hospitalier de Luxembourg · LULaboratoire National de Santé · LULuxembourg Institute of Health · LUPacific Northwest Diabetes Research Institute · USUniversity of Tennessee Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dopaminergic neurons in the midbrain are of particular interest due to their role in diseases such as Parkinson's disease and schizophrenia. Genetic variation between individuals can affect the integrity and function of dopaminergic neurons but the DNA variants and molecular cascades modulating dopaminergic neurons and other cells types of ventral midbrain remain poorly defined. Three genetically diverse inbred mouse strains - C57BL/6J, A/J, and DBA/2J - differ significantly in their genomes (∼7 million variants), motor and cognitive behavior, and susceptibility to neurotoxins. To further dissect the underlying molecular networks responsible for these variable phenotypes, we generated RNA-seq and ChIP-seq data from ventral midbrains of the 3 mouse strains. We defined 1000-1200 transcripts that are differentially expressed among them. These widespread differences may be due to altered activity or expression of upstream transcription factors. Interestingly, transcription factors were significantly underrepresented among the differentially expressed genes, and only one transcription factor,

Indexed as

agingmidbrainmouse strainsPttg1regulatory variation

Identifiers

PMID33173537
PMCPMC7538689
OpenAlexW3088513663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.